A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

December 16, 2024

Primary Completion Date

February 15, 2028

Study Completion Date

August 15, 2028

Conditions
Squamous Non-small-cell Lung CancerHead and Neck Squamous Cell CarcinomaCervical Squamous Cell CarcinomaEsophageal Squamous Cell Carcinoma
Interventions
DRUG

ALE.P02

ALE.P02, will be administered by IV infusion according to the assigned arms.

Trial Locations (30)

10408

RECRUITING

National Cancer Center, Goyang-si

11907

RECRUITING

National University Cancer Institue, Singapore

20132

RECRUITING

Ospedale San Raffaele, IRCCS, Milan

20141

RECRUITING

IEO - Istituto Europeo di Oncologia, IRCCS, Milan

22031

RECRUITING

NEXT Oncology Virginia, Fairfax

28050

RECRUITING

START Madrid- Centro Integral Oncologico Clara Campal, PAU de Sanchinarro

28223

RECRUITING

Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón

29010

RECRUITING

Hospital Universitario Virgen De La Victoria, Málaga

40202

RECRUITING

Norton Cancer Institue Downtown, Louisville

46026

RECRUITING

Hospital Universitario Y Politécnico La Fe, Valencia

48121

RECRUITING

Ospedale Santa Maria delle Croci di Ravenna Oncologia, Ravenna

50006

RECRUITING

Changhua Christian Medical Foundation Changhua Christian Hospital, Changhua

60637

RECRUITING

The University of Chicago Medical Center - Oncology, Chicago

85259

RECRUITING

Mayo Foundation for Medical Education and Research - Mayo Cl, Scottsdale

90033

RECRUITING

USC Norris Comprehensive Cancer Center, Los Angeles

92835

RECRUITING

Providence Medical Foundation, Fullerton

94800

RECRUITING

Institut Gustave Roussy, Villejuif

100225

RECRUITING

National Taiwan University Hospital, Taipei

168583

RECRUITING

National Cancer Centre Singapore, Singapore

231020

RECRUITING

Buddihist Tzu Chi Medical Foundation - Taipei Tzu Chi Hospital, Taipei

500209

RECRUITING

Changhua Christian Medical Foundation Changhua Christian Hospital, Changhua

06510

RECRUITING

Yale Comprehensive Cancer Center, New Haven

07601

RECRUITING

Hackensack University Medical Center, Hackensack

Unknown

RECRUITING

Chinese University of Hong Kong - Prince of Wales Hospital, Shatin

RECRUITING

PU A. Gemelli, Universita Cattolica del Sacro Cuore, Roma

RECRUITING

Centro Ricerche Cliniche Verona, Verona

RECRUITING

START Hospital HM Nou Delfos, Barcelona

03080

RECRUITING

Seoul National University Hospital, Seoul

03722

RECRUITING

Severance Hospital, Yonsei University Health System, Seoul

08035

RECRUITING

Hospital Universitari Vall D Hebron, Barcelona

Sponsors
All Listed Sponsors
lead

Alentis Therapeutics AG

INDUSTRY

NCT06747585 - A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors | Biotech Hunter | Biotech Hunter